

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | adult feeding behavior (GO:0008343) | 8.87090857 |
| 2 | regulation of neurotransmitter uptake (GO:0051580) | 8.38734346 |
| 3 | arginine catabolic process (GO:0006527) | 7.98319442 |
| 4 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 7.76443701 |
| 5 | endothelium development (GO:0003158) | 7.35526096 |
| 6 | neurotransmitter biosynthetic process (GO:0042136) | 7.31862247 |
| 7 | definitive hemopoiesis (GO:0060216) | 7.26522759 |
| 8 | negative regulation of neurotransmitter transport (GO:0051589) | 6.96079012 |
| 9 | peptidyl-cysteine modification (GO:0018198) | 6.77947607 |
| 10 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 6.69003713 |
| 11 | positive regulation of action potential (GO:0045760) | 6.42165392 |
| 12 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 6.37057907 |
| 13 | succinate metabolic process (GO:0006105) | 6.18552335 |
| 14 | seminiferous tubule development (GO:0072520) | 6.07851546 |
| 15 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.00458142 |
| 16 | regulation of response to food (GO:0032095) | 5.86958010 |
| 17 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 5.49210980 |
| 18 | regulation of female receptivity (GO:0045924) | 5.38720720 |
| 19 | regulation of guanylate cyclase activity (GO:0031282) | 5.38420987 |
| 20 | neurotransmitter metabolic process (GO:0042133) | 5.27601899 |
| 21 | positive regulation of vasculogenesis (GO:2001214) | 5.27276219 |
| 22 | arginine metabolic process (GO:0006525) | 5.25334724 |
| 23 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 5.16576152 |
| 24 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 5.16576152 |
| 25 | female mating behavior (GO:0060180) | 5.02822847 |
| 26 | glutamine family amino acid catabolic process (GO:0009065) | 5.01808316 |
| 27 | phagosome maturation (GO:0090382) | 5.01742245 |
| 28 | regulation of appetite (GO:0032098) | 4.98503982 |
| 29 | positive regulation of response to extracellular stimulus (GO:0032106) | 4.97436066 |
| 30 | positive regulation of response to nutrient levels (GO:0032109) | 4.97436066 |
| 31 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 4.90245463 |
| 32 | nitric oxide mediated signal transduction (GO:0007263) | 4.61556570 |
| 33 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.60772457 |
| 34 | positive regulation of B cell differentiation (GO:0045579) | 4.60229421 |
| 35 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 4.58487082 |
| 36 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.55489485 |
| 37 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.55489485 |
| 38 | megakaryocyte development (GO:0035855) | 4.53437203 |
| 39 | urinary tract smooth muscle contraction (GO:0014848) | 4.51567605 |
| 40 | epithelial cell differentiation involved in kidney development (GO:0035850) | 4.46517984 |
| 41 | synaptic vesicle exocytosis (GO:0016079) | 4.46333872 |
| 42 | regulation of uterine smooth muscle contraction (GO:0070472) | 4.46019772 |
| 43 | thrombin receptor signaling pathway (GO:0070493) | 4.38080465 |
| 44 | positive regulation of histone acetylation (GO:0035066) | 4.36034330 |
| 45 | branched-chain amino acid catabolic process (GO:0009083) | 4.31254870 |
| 46 | hyperosmotic salinity response (GO:0042538) | 4.30919196 |
| 47 | nitric oxide biosynthetic process (GO:0006809) | 4.30686853 |
| 48 | positive regulation of cGMP biosynthetic process (GO:0030828) | 4.28593397 |
| 49 | transferrin transport (GO:0033572) | 4.27961943 |
| 50 | protein-cofactor linkage (GO:0018065) | 4.26256506 |
| 51 | maternal behavior (GO:0042711) | 4.25213062 |
| 52 | drinking behavior (GO:0042756) | 4.23233621 |
| 53 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.17545136 |
| 54 | branched-chain amino acid metabolic process (GO:0009081) | 4.14848169 |
| 55 | Rac protein signal transduction (GO:0016601) | 4.12363058 |
| 56 | tachykinin receptor signaling pathway (GO:0007217) | 4.11368498 |
| 57 | parental behavior (GO:0060746) | 4.07607822 |
| 58 | ferric iron transport (GO:0015682) | 4.05514529 |
| 59 | trivalent inorganic cation transport (GO:0072512) | 4.05514529 |
| 60 | neurotransmitter secretion (GO:0007269) | 4.01009105 |
| 61 | regulation of cGMP biosynthetic process (GO:0030826) | 4.00229844 |
| 62 | relaxation of smooth muscle (GO:0044557) | 3.93983683 |
| 63 | positive regulation of vascular permeability (GO:0043117) | 3.92121472 |
| 64 | positive regulation of amino acid transport (GO:0051957) | 3.91782034 |
| 65 | dicarboxylic acid catabolic process (GO:0043649) | 3.86338335 |
| 66 | * aggressive behavior (GO:0002118) | 3.86170310 |
| 67 | positive regulation of protein acetylation (GO:1901985) | 3.85300770 |
| 68 | positive regulation of peptidyl-lysine acetylation (GO:2000758) | 3.85300770 |
| 69 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.81493164 |
| 70 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.79197064 |
| 71 | DNA deamination (GO:0045006) | 3.78090030 |
| 72 | positive regulation of cGMP metabolic process (GO:0030825) | 3.75219937 |
| 73 | myoblast fusion (GO:0007520) | 3.71469108 |
| 74 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.64066098 |
| 75 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.64043643 |
| 76 | cellular response to exogenous dsRNA (GO:0071360) | 3.63103876 |
| 77 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.62662912 |
| 78 | neuron cell-cell adhesion (GO:0007158) | 3.62282683 |
| 79 | valine metabolic process (GO:0006573) | 3.59798103 |
| 80 | interkinetic nuclear migration (GO:0022027) | 3.59492513 |
| 81 | regulation of action potential (GO:0098900) | 3.59051042 |
| 82 | positive regulation of sodium ion transport (GO:0010765) | 3.58892416 |
| 83 | immunoglobulin mediated immune response (GO:0016064) | 3.57586731 |
| 84 | positive regulation of neurotransmitter transport (GO:0051590) | 3.57108807 |
| 85 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.56100594 |
| 86 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.55411189 |
| 87 | regulation of vasculogenesis (GO:2001212) | 3.54550436 |
| 88 | inositol metabolic process (GO:0006020) | 3.54477326 |
| 89 | vocalization behavior (GO:0071625) | 3.54407064 |
| 90 | negative regulation of potassium ion transport (GO:0043267) | 3.53887860 |
| 91 | positive regulation of amine transport (GO:0051954) | 3.53414535 |
| 92 | regulation of neurotransmitter levels (GO:0001505) | 3.52866079 |
| 93 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.52593678 |
| 94 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.50692535 |
| 95 | regulation of the force of heart contraction (GO:0002026) | 3.48243636 |
| 96 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.47823908 |
| 97 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.43482305 |
| 98 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.43441375 |
| 99 | cell differentiation involved in metanephros development (GO:0072202) | 3.42001955 |
| 100 | NADH metabolic process (GO:0006734) | 3.38053253 |
| 101 | response to interferon-beta (GO:0035456) | 3.37531560 |
| 102 | glutamate secretion (GO:0014047) | 3.36183910 |
| 103 | synaptic transmission, glutamatergic (GO:0035249) | 3.36001545 |
| 104 | regulation of cGMP metabolic process (GO:0030823) | 3.33691564 |
| 105 | response to auditory stimulus (GO:0010996) | 3.33449504 |
| 106 | grooming behavior (GO:0007625) | 3.31822890 |
| 107 | amino acid salvage (GO:0043102) | 3.28504183 |
| 108 | L-methionine salvage (GO:0071267) | 3.28504183 |
| 109 | L-methionine biosynthetic process (GO:0071265) | 3.28504183 |
| 110 | autophagic vacuole fusion (GO:0000046) | 3.27306091 |
| 111 | platelet dense granule organization (GO:0060155) | 3.27296534 |
| 112 | negative regulation of digestive system process (GO:0060457) | 3.26240595 |
| 113 | negative regulation of synaptic transmission (GO:0050805) | 3.25967103 |
| 114 | regulation of neurotransmitter transport (GO:0051588) | 3.23203167 |
| 115 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.22887262 |
| 116 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.22341908 |
| 117 | synaptic vesicle maturation (GO:0016188) | 3.22008752 |
| 118 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.21827407 |
| 119 | phagocytosis, engulfment (GO:0006911) | 3.21766961 |
| 120 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.21409601 |
| 121 | Peyers patch development (GO:0048541) | 3.21409601 |
| 122 | mature B cell differentiation involved in immune response (GO:0002313) | 3.20771542 |
| 123 | regulation of transmission of nerve impulse (GO:0051969) | 3.19840135 |
| 124 | purine nucleotide salvage (GO:0032261) | 3.18824004 |
| 125 | regulation of synaptic vesicle transport (GO:1902803) | 3.18664822 |
| 126 | regulation of sodium ion transmembrane transport (GO:1902305) | 3.18327616 |
| 127 | neuronal action potential propagation (GO:0019227) | 3.17598914 |
| 128 | forebrain morphogenesis (GO:0048853) | 3.17343407 |
| 129 | B cell mediated immunity (GO:0019724) | 3.16995601 |
| 130 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.16328450 |
| 131 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.14736987 |
| 132 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.14143237 |
| 133 | iron-sulfur cluster assembly (GO:0016226) | 3.13290713 |
| 134 | metallo-sulfur cluster assembly (GO:0031163) | 3.13290713 |
| 135 | cGMP biosynthetic process (GO:0006182) | 3.13040399 |
| 136 | oxaloacetate metabolic process (GO:0006107) | 3.08404219 |
| 137 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.07127687 |
| 138 | gamma-aminobutyric acid transport (GO:0015812) | 3.06725583 |
| 139 | central nervous system neuron development (GO:0021954) | 3.05014689 |
| 140 | * neuron-neuron synaptic transmission (GO:0007270) | 3.03989962 |
| 141 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.03400758 |
| 142 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.03209056 |
| 143 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.02327173 |
| 144 | positive regulation of digestive system process (GO:0060456) | 3.02054607 |
| 145 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.99153997 |
| 146 | opioid receptor signaling pathway (GO:0038003) | 2.97936513 |
| 147 | neurotransmitter transport (GO:0006836) | 2.97623363 |
| 148 | regulation of B cell differentiation (GO:0045577) | 2.96665384 |
| 149 | deoxyribonucleotide catabolic process (GO:0009264) | 2.96071265 |
| 150 | glutamate receptor signaling pathway (GO:0007215) | 2.95747276 |
| 151 | cGMP metabolic process (GO:0046068) | 2.95677841 |
| 152 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.94055238 |
| 153 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.92161567 |
| 154 | regulation of antigen processing and presentation (GO:0002577) | 2.92139680 |
| 155 | basic amino acid transport (GO:0015802) | 2.91696066 |
| 156 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91684336 |
| 157 | presynaptic membrane organization (GO:0097090) | 2.90641837 |
| 158 | neutrophil activation involved in immune response (GO:0002283) | 2.90350347 |
| 159 | deoxyribose phosphate catabolic process (GO:0046386) | 2.88790996 |
| 160 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.87775297 |
| 161 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.85182927 |
| 162 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.84117423 |
| 163 | ubiquinone biosynthetic process (GO:0006744) | 2.83201321 |
| 164 | mannosylation (GO:0097502) | 2.80113020 |
| 165 | purine-containing compound salvage (GO:0043101) | 2.79966567 |
| 166 | hematopoietic stem cell proliferation (GO:0071425) | 2.77062979 |
| 167 | GPI anchor biosynthetic process (GO:0006506) | 2.74722955 |
| 168 | positive regulation of antigen processing and presentation (GO:0002579) | 2.74694064 |
| 169 | estrogen biosynthetic process (GO:0006703) | 2.74420667 |
| 170 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.71407741 |
| 171 | positive regulation of organic acid transport (GO:0032892) | 2.71204938 |
| 172 | regulation of glutamate secretion (GO:0014048) | 2.68052473 |
| 173 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.66607332 |
| 174 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.66607332 |
| 175 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.66049852 |
| 176 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.63444994 |
| 177 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.62989287 |
| 178 | organelle membrane fusion (GO:0090174) | 2.62431082 |
| 179 | inositol phosphate dephosphorylation (GO:0046855) | 2.58361010 |
| 180 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.58361010 |
| 181 | ribosomal small subunit assembly (GO:0000028) | 2.57754886 |
| 182 | thyroid gland development (GO:0030878) | 2.57020262 |
| 183 | tryptophan metabolic process (GO:0006568) | 2.55982027 |
| 184 | positive regulation of G1/S transition of mitotic cell cycle (GO:1900087) | 2.55251636 |
| 185 | endoderm formation (GO:0001706) | 2.54853363 |
| 186 | GPI anchor metabolic process (GO:0006505) | 2.53168851 |
| 187 | nucleotide salvage (GO:0043173) | 2.53125316 |
| 188 | indole-containing compound catabolic process (GO:0042436) | 2.51002726 |
| 189 | indolalkylamine catabolic process (GO:0046218) | 2.51002726 |
| 190 | tryptophan catabolic process (GO:0006569) | 2.51002726 |
| 191 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50990886 |
| 192 | organ formation (GO:0048645) | 2.50562029 |
| 193 | histamine secretion (GO:0001821) | 2.49204719 |
| 194 | monoamine transport (GO:0015844) | 2.47682250 |
| 195 | positive thymic T cell selection (GO:0045059) | 2.47627896 |
| 196 | protein kinase C signaling (GO:0070528) | 2.47113537 |
| 197 | xenobiotic catabolic process (GO:0042178) | 2.46762612 |
| 198 | exogenous drug catabolic process (GO:0042738) | 15.6636257 |
| 199 | drug catabolic process (GO:0042737) | 12.5290996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 5.96012778 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.96886351 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.78357542 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.59462023 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.44037692 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.10257182 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.81981066 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.59815974 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.56548816 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.28164657 |
| 11 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.23083049 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.89486993 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.83035611 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65895205 |
| 15 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.57281676 |
| 16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53995352 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.50923297 |
| 18 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50591825 |
| 19 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49980773 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.48714846 |
| 21 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.47359832 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.40210037 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.37733351 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.37733351 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.33923909 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.29842512 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.24549132 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.21369450 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.21141225 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19071318 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 2.18975320 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.17732476 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.17565321 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 2.15416669 |
| 35 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.12297216 |
| 36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.08233634 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.02719101 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02459450 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01656777 |
| 40 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01260848 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.99456136 |
| 42 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.96299056 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.93345546 |
| 44 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.93109966 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.92561308 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.89407279 |
| 47 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88563217 |
| 48 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.85723688 |
| 49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.76491504 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.76093684 |
| 51 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.72522391 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.71395689 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.70973319 |
| 54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.69867530 |
| 55 | FUS_26573619_Chip-Seq_HEK293_Human | 1.69368809 |
| 56 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.68979731 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.67204016 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.66589004 |
| 59 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.64575329 |
| 60 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64173052 |
| 61 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.61678614 |
| 62 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57430478 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.57219943 |
| 64 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.56723954 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.56639666 |
| 66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.55725287 |
| 67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.54217279 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.53918017 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53869069 |
| 70 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.52594694 |
| 71 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52087637 |
| 72 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.50385991 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.50112699 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49114200 |
| 75 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.48641568 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.47041424 |
| 77 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46843577 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.46060276 |
| 79 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.43429192 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43255353 |
| 81 | JUN_21703547_ChIP-Seq_K562_Human | 1.42356467 |
| 82 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.42354974 |
| 83 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39637698 |
| 84 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39541780 |
| 85 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39203876 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37910914 |
| 87 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36397423 |
| 88 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35519759 |
| 89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35372926 |
| 90 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34621763 |
| 91 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.33724586 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33721272 |
| 93 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33399257 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.32679445 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.28386725 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.28386725 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.28340539 |
| 98 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28339238 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28032353 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28014366 |
| 101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28014366 |
| 102 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26937941 |
| 103 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.25614382 |
| 104 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.25614382 |
| 105 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.23979546 |
| 106 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.23770625 |
| 107 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23531072 |
| 108 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23164524 |
| 109 | MYB_26560356_Chip-Seq_TH2_Human | 1.22237327 |
| 110 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.22064589 |
| 111 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.20370205 |
| 112 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19947082 |
| 113 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19901034 |
| 114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19049248 |
| 115 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18552594 |
| 116 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.17939560 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17698109 |
| 118 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.17316629 |
| 119 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17289838 |
| 120 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.16535661 |
| 121 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.16359931 |
| 122 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.16271653 |
| 123 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.15919626 |
| 124 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14751803 |
| 125 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14157042 |
| 126 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12927164 |
| 127 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.12200536 |
| 128 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10563737 |
| 129 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.10388541 |
| 130 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10234442 |
| 131 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10218446 |
| 132 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.10135975 |
| 133 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08238974 |
| 134 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07971649 |
| 135 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07911397 |
| 136 | AR_20517297_ChIP-Seq_VCAP_Human | 1.06231659 |
| 137 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04369271 |
| 138 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03714675 |
| 139 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03319026 |
| 140 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03063403 |
| 141 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.02722720 |
| 142 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02273876 |
| 143 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01697499 |
| 144 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01466002 |
| 145 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.01416913 |
| 146 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.00998148 |
| 147 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98284668 |
| 148 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97901460 |
| 149 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97870357 |
| 150 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97833960 |
| 151 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97728058 |
| 152 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97348015 |
| 153 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97033293 |
| 154 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96379250 |
| 155 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96365349 |
| 156 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95863103 |
| 157 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95498048 |
| 158 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93990154 |
| 159 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.93395475 |
| 160 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93380907 |
| 161 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92782415 |
| 162 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92535741 |
| 163 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.89665622 |
| 164 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.89144576 |
| 165 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88811009 |
| 166 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88811009 |
| 167 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.87964001 |
| 168 | AR_19668381_ChIP-Seq_PC3_Human | 0.87558746 |
| 169 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.87397206 |
| 170 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.86605674 |
| 171 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86151545 |
| 172 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.85917463 |
| 173 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.85660101 |
| 174 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85651228 |
| 175 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85648687 |
| 176 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85018370 |
| 177 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.84623506 |
| 178 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.84451580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 7.16057712 |
| 2 | MP0006054_spinal_hemorrhage | 5.73265236 |
| 3 | MP0001529_abnormal_vocalization | 4.98516650 |
| 4 | MP0005645_abnormal_hypothalamus_physiol | 4.98218949 |
| 5 | MP0004858_abnormal_nervous_system | 4.67968173 |
| 6 | MP0004043_abnormal_pH_regulation | 3.72176658 |
| 7 | MP0004233_abnormal_muscle_weight | 3.51869518 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 3.47814727 |
| 9 | MP0001501_abnormal_sleep_pattern | 3.33454857 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 3.16062216 |
| 11 | MP0002736_abnormal_nociception_after | 3.08500646 |
| 12 | MP0004084_abnormal_cardiac_muscle | 3.06400328 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.90961708 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.90961708 |
| 15 | MP0003045_fibrosis | 2.90370273 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.90316400 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.80715965 |
| 18 | MP0000465_gastrointestinal_hemorrhage | 2.78043884 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 2.77962180 |
| 20 | MP0003283_abnormal_digestive_organ | 2.71114399 |
| 21 | MP0006292_abnormal_olfactory_placode | 2.70549861 |
| 22 | MP0009278_abnormal_bone_marrow | 2.66859402 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 2.62301764 |
| 24 | MP0002064_seizures | 2.59046245 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 2.52960002 |
| 26 | MP0001968_abnormal_touch/_nociception | 2.51544389 |
| 27 | MP0002272_abnormal_nervous_system | 2.46917371 |
| 28 | MP0009046_muscle_twitch | 2.46880288 |
| 29 | MP0009745_abnormal_behavioral_response | 2.46601091 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 2.43075331 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 2.42299619 |
| 32 | MP0002735_abnormal_chemical_nociception | 2.38153290 |
| 33 | MP0008775_abnormal_heart_ventricle | 2.37613274 |
| 34 | MP0004036_abnormal_muscle_relaxation | 2.33588951 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 2.27206231 |
| 36 | MP0008004_abnormal_stomach_pH | 2.26700712 |
| 37 | MP0001440_abnormal_grooming_behavior | 2.26180023 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 2.24618327 |
| 39 | MP0003787_abnormal_imprinting | 2.21831879 |
| 40 | MP0008872_abnormal_physiological_respon | 2.17579370 |
| 41 | MP0003724_increased_susceptibility_to | 2.09089063 |
| 42 | MP0003195_calcinosis | 2.06989876 |
| 43 | MP0003122_maternal_imprinting | 2.03830865 |
| 44 | MP0004883_abnormal_blood_vessel | 1.95735891 |
| 45 | MP0008875_abnormal_xenobiotic_pharmacok | 1.91351232 |
| 46 | MP0004484_altered_response_of | 1.90401529 |
| 47 | * MP0002572_abnormal_emotion/affect_behav | 1.80938273 |
| 48 | MP0002063_abnormal_learning/memory/cond | 1.73708632 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.69334605 |
| 50 | MP0005367_renal/urinary_system_phenotyp | 1.64746066 |
| 51 | MP0000516_abnormal_urinary_system | 1.64746066 |
| 52 | MP0008058_abnormal_DNA_repair | 1.63889850 |
| 53 | MP0000467_abnormal_esophagus_morphology | 1.63876560 |
| 54 | MP0000681_abnormal_thyroid_gland | 1.62715096 |
| 55 | MP0008995_early_reproductive_senescence | 1.60877516 |
| 56 | MP0006138_congestive_heart_failure | 1.58523308 |
| 57 | MP0003880_abnormal_central_pattern | 1.56983449 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.55070342 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.54841692 |
| 60 | MP0001835_abnormal_antigen_presentation | 1.54234647 |
| 61 | MP0002734_abnormal_mechanical_nocicepti | 1.50929155 |
| 62 | MP0002876_abnormal_thyroid_physiology | 1.45919959 |
| 63 | MP0001970_abnormal_pain_threshold | 1.43607155 |
| 64 | MP0003315_abnormal_perineum_morphology | 1.42039261 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.41529721 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.38862984 |
| 67 | MP0004924_abnormal_behavior | 1.38862984 |
| 68 | MP0002234_abnormal_pharynx_morphology | 1.35396786 |
| 69 | MP0002132_abnormal_respiratory_system | 1.28502660 |
| 70 | MP0001664_abnormal_digestion | 1.28213932 |
| 71 | MP0001764_abnormal_homeostasis | 1.27310656 |
| 72 | MP0006276_abnormal_autonomic_nervous | 1.25058282 |
| 73 | MP0009250_abnormal_appendicular_skeleto | 1.24972262 |
| 74 | MP0003718_maternal_effect | 1.24315821 |
| 75 | MP0003943_abnormal_hepatobiliary_system | 1.23188920 |
| 76 | MP0003075_altered_response_to | 1.22099365 |
| 77 | MP0003866_abnormal_defecation | 1.22008042 |
| 78 | MP0002557_abnormal_social/conspecific_i | 1.16216012 |
| 79 | MP0008877_abnormal_DNA_methylation | 1.15825272 |
| 80 | MP0004811_abnormal_neuron_physiology | 1.15259867 |
| 81 | MP0001879_abnormal_lymphatic_vessel | 1.10693341 |
| 82 | MP0008874_decreased_physiological_sensi | 1.06333196 |
| 83 | MP0000013_abnormal_adipose_tissue | 1.05498818 |
| 84 | MP0002733_abnormal_thermal_nociception | 1.04242777 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 1.04092579 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 1.03444729 |
| 87 | MP0002184_abnormal_innervation | 1.01520643 |
| 88 | MP0005410_abnormal_fertilization | 1.01504766 |
| 89 | MP0002067_abnormal_sensory_capabilities | 1.00640040 |
| 90 | MP0005423_abnormal_somatic_nervous | 1.00176690 |
| 91 | MP0001486_abnormal_startle_reflex | 0.96110315 |
| 92 | MP0004270_analgesia | 0.96105215 |
| 93 | MP0004142_abnormal_muscle_tone | 0.95422669 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 0.95365555 |
| 95 | MP0003279_aneurysm | 0.95072652 |
| 96 | MP0002168_other_aberrant_phenotype | 0.92826289 |
| 97 | MP0003633_abnormal_nervous_system | 0.92625546 |
| 98 | MP0005164_abnormal_response_to | 0.87304037 |
| 99 | MP0001905_abnormal_dopamine_level | 0.87083396 |
| 100 | MP0002398_abnormal_bone_marrow | 0.86419788 |
| 101 | MP0002127_abnormal_cardiovascular_syste | 0.86406671 |
| 102 | MP0001984_abnormal_olfaction | 0.85051301 |
| 103 | MP0000955_abnormal_spinal_cord | 0.82362676 |
| 104 | MP0000689_abnormal_spleen_morphology | 0.82175202 |
| 105 | MP0000751_myopathy | 0.81243137 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.80993742 |
| 107 | MP0004145_abnormal_muscle_electrophysio | 0.80898240 |
| 108 | MP0003121_genomic_imprinting | 0.79745925 |
| 109 | MP0008469_abnormal_protein_level | 0.79715554 |
| 110 | MP0005000_abnormal_immune_tolerance | 0.79682392 |
| 111 | MP0003252_abnormal_bile_duct | 0.79636156 |
| 112 | MP0002822_catalepsy | 0.78656684 |
| 113 | MP0005165_increased_susceptibility_to | 0.78206203 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.78142309 |
| 115 | MP0005197_abnormal_uvea_morphology | 0.78043710 |
| 116 | MP0001666_abnormal_nutrient_absorption | 0.77398212 |
| 117 | MP0003631_nervous_system_phenotype | 0.75776437 |
| 118 | MP0010329_abnormal_lipoprotein_level | 0.73496776 |
| 119 | MP0002928_abnormal_bile_duct | 0.73428254 |
| 120 | MP0003303_peritoneal_inflammation | 0.73209867 |
| 121 | MP0001851_eye_inflammation | 0.72878525 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.72360460 |
| 123 | MP0001663_abnormal_digestive_system | 0.71194652 |
| 124 | MP0004085_abnormal_heartbeat | 0.70338192 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.70213377 |
| 126 | MP0002066_abnormal_motor_capabilities/c | 0.69733658 |
| 127 | MP0002019_abnormal_tumor_incidence | 0.69503718 |
| 128 | MP0005360_urolithiasis | 0.69028863 |
| 129 | MP0002009_preneoplasia | 0.68515015 |
| 130 | MP0004147_increased_porphyrin_level | 0.68303306 |
| 131 | MP0003329_amyloid_beta_deposits | 0.67445539 |
| 132 | MP0005551_abnormal_eye_electrophysiolog | 0.65709195 |
| 133 | MP0001119_abnormal_female_reproductive | 0.65654233 |
| 134 | MP0003786_premature_aging | 0.65144203 |
| 135 | MP0000049_abnormal_middle_ear | 0.64915267 |
| 136 | MP0003186_abnormal_redox_activity | 0.64451786 |
| 137 | MP0005394_taste/olfaction_phenotype | 0.64235882 |
| 138 | MP0005499_abnormal_olfactory_system | 0.64235882 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.62800458 |
| 140 | MP0004215_abnormal_myocardial_fiber | 0.62581403 |
| 141 | MP0005535_abnormal_body_temperature | 0.62064980 |
| 142 | MP0002909_abnormal_adrenal_gland | 0.61778717 |
| 143 | MP0005220_abnormal_exocrine_pancreas | 0.61403331 |
| 144 | MP0001177_atelectasis | 0.61287684 |
| 145 | MP0009764_decreased_sensitivity_to | 0.60986057 |
| 146 | MP0002419_abnormal_innate_immunity | 0.60776922 |
| 147 | MP0002429_abnormal_blood_cell | 0.60526867 |
| 148 | MP0002723_abnormal_immune_serum | 0.59904914 |
| 149 | MP0003119_abnormal_digestive_system | 0.59698912 |
| 150 | MP0000598_abnormal_liver_morphology | 0.59280312 |
| 151 | MP0002932_abnormal_joint_morphology | 0.59181960 |
| 152 | MP0001661_extended_life_span | 0.59075334 |
| 153 | MP0009697_abnormal_copulation | 0.58403499 |
| 154 | MP0002160_abnormal_reproductive_system | 0.57936548 |
| 155 | MP0002722_abnormal_immune_system | 0.57818189 |
| 156 | MP0001929_abnormal_gametogenesis | 0.57644450 |
| 157 | MP0002420_abnormal_adaptive_immunity | 0.57608015 |
| 158 | MP0005166_decreased_susceptibility_to | 0.57406478 |
| 159 | MP0003879_abnormal_hair_cell | 0.56980553 |
| 160 | MP0002882_abnormal_neuron_morphology | 0.56729565 |
| 161 | MP0005623_abnormal_meninges_morphology | 0.56527938 |
| 162 | MP0008569_lethality_at_weaning | 0.55520138 |
| 163 | MP0005332_abnormal_amino_acid | 0.54561945 |
| 164 | MP0002254_reproductive_system_inflammat | 0.52522860 |
| 165 | * MP0002069_abnormal_eating/drinking_beha | 0.50827452 |
| 166 | MP0005646_abnormal_pituitary_gland | 0.49880254 |
| 167 | MP0001986_abnormal_taste_sensitivity | 0.49239646 |
| 168 | MP0000470_abnormal_stomach_morphology | 0.48882432 |
| 169 | MP0003183_abnormal_peptide_metabolism | 0.48131072 |
| 170 | MP0005376_homeostasis/metabolism_phenot | 0.48056188 |
| 171 | MP0001943_abnormal_respiration | 0.47486600 |
| 172 | MP0005381_digestive/alimentary_phenotyp | 0.46344046 |
| 173 | MP0002972_abnormal_cardiac_muscle | 0.43607229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal hair whorl (HP:0010721) | 6.78905431 |
| 2 | Oligomenorrhea (HP:0000876) | 6.14750413 |
| 3 | Abnormality of the labia minora (HP:0012880) | 5.38497282 |
| 4 | Neuroendocrine neoplasm (HP:0100634) | 4.98563434 |
| 5 | Focal motor seizures (HP:0011153) | 4.84206657 |
| 6 | Myokymia (HP:0002411) | 4.77719679 |
| 7 | Polyphagia (HP:0002591) | 4.72094314 |
| 8 | Pheochromocytoma (HP:0002666) | 4.62935715 |
| 9 | Poor suck (HP:0002033) | 4.46853472 |
| 10 | Failure to thrive in infancy (HP:0001531) | 4.42654760 |
| 11 | Dyschromatopsia (HP:0007641) | 4.36486915 |
| 12 | Gonadal dysgenesis (HP:0000133) | 4.34559213 |
| 13 | Atonic seizures (HP:0010819) | 4.23010544 |
| 14 | Abolished electroretinogram (ERG) (HP:0000550) | 4.16779574 |
| 15 | Spastic diplegia (HP:0001264) | 4.12142893 |
| 16 | Abnormality of the 1st metacarpal (HP:0010009) | 4.01536744 |
| 17 | Resting tremor (HP:0002322) | 3.83143230 |
| 18 | Focal seizures (HP:0007359) | 3.82388105 |
| 19 | Thrombocytosis (HP:0001894) | 3.74335705 |
| 20 | Narrow nasal bridge (HP:0000446) | 3.72376808 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 3.64906804 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.59591953 |
| 23 | Epileptic encephalopathy (HP:0200134) | 3.56951931 |
| 24 | Acute necrotizing encephalopathy (HP:0006965) | 3.49703358 |
| 25 | Abnormal eating behavior (HP:0100738) | 3.43394102 |
| 26 | Decreased central vision (HP:0007663) | 3.42547612 |
| 27 | Visual hallucinations (HP:0002367) | 3.38696157 |
| 28 | Absence seizures (HP:0002121) | 3.37635604 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.34720337 |
| 30 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.19015210 |
| 31 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.17593895 |
| 32 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.16192842 |
| 33 | Abnormality of pain sensation (HP:0010832) | 3.14905640 |
| 34 | Impaired pain sensation (HP:0007328) | 3.14905640 |
| 35 | Short phalanx of the thumb (HP:0009660) | 3.14197824 |
| 36 | Increased intramyocellular lipid droplets (HP:0012240) | 3.12191776 |
| 37 | Abnormality of the vocal cords (HP:0008777) | 3.11987660 |
| 38 | Progressive cerebellar ataxia (HP:0002073) | 3.10218868 |
| 39 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.09445953 |
| 40 | Increased muscle lipid content (HP:0009058) | 3.06585917 |
| 41 | Facial diplegia (HP:0001349) | 3.02901355 |
| 42 | Febrile seizures (HP:0002373) | 3.00772807 |
| 43 | Progressive macrocephaly (HP:0004481) | 2.99143646 |
| 44 | Generalized hypotonia (HP:0001290) | 2.95236360 |
| 45 | Epileptiform EEG discharges (HP:0011182) | 2.92691757 |
| 46 | Increased serum pyruvate (HP:0003542) | 2.91058773 |
| 47 | Abnormality of glycolysis (HP:0004366) | 2.91058773 |
| 48 | Hypothermia (HP:0002045) | 2.89400606 |
| 49 | Aplastic anemia (HP:0001915) | 2.87999540 |
| 50 | Hypoventilation (HP:0002791) | 2.87575241 |
| 51 | Esotropia (HP:0000565) | 2.87192551 |
| 52 | Hyperventilation (HP:0002883) | 2.86171687 |
| 53 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.84905627 |
| 54 | Short 1st metacarpal (HP:0010034) | 2.84905627 |
| 55 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.80399671 |
| 56 | Mitochondrial inheritance (HP:0001427) | 2.79968629 |
| 57 | Abnormality of macular pigmentation (HP:0008002) | 2.79749934 |
| 58 | Acute encephalopathy (HP:0006846) | 2.79234387 |
| 59 | Hip dysplasia (HP:0001385) | 2.78526894 |
| 60 | Tongue fasciculations (HP:0001308) | 2.75735317 |
| 61 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.75168301 |
| 62 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.75168301 |
| 63 | Abnormal protein glycosylation (HP:0012346) | 2.75168301 |
| 64 | Abnormal glycosylation (HP:0012345) | 2.75168301 |
| 65 | Methylmalonic acidemia (HP:0002912) | 2.74514564 |
| 66 | Hyperglycinemia (HP:0002154) | 2.74236664 |
| 67 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.74172198 |
| 68 | Dialeptic seizures (HP:0011146) | 2.74098919 |
| 69 | Short tibia (HP:0005736) | 2.72607980 |
| 70 | Gonadotropin excess (HP:0000837) | 2.70785061 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.68805411 |
| 72 | Cholecystitis (HP:0001082) | 2.68805411 |
| 73 | Reduced antithrombin III activity (HP:0001976) | 2.67058837 |
| 74 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.67044454 |
| 75 | Dysdiadochokinesis (HP:0002075) | 2.64431797 |
| 76 | Acute lymphatic leukemia (HP:0006721) | 2.64427201 |
| 77 | EEG with generalized epileptiform discharges (HP:0011198) | 2.63218135 |
| 78 | Specific learning disability (HP:0001328) | 2.60596507 |
| 79 | Hypsarrhythmia (HP:0002521) | 2.60195416 |
| 80 | Hepatocellular necrosis (HP:0001404) | 2.59035714 |
| 81 | Attenuation of retinal blood vessels (HP:0007843) | 2.58617519 |
| 82 | Lipid accumulation in hepatocytes (HP:0006561) | 2.57506324 |
| 83 | Central scotoma (HP:0000603) | 2.56950202 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.56071729 |
| 85 | Epistaxis (HP:0000421) | 2.55413162 |
| 86 | Labial hypoplasia (HP:0000066) | 2.52830093 |
| 87 | Abnormality of the prostate (HP:0008775) | 2.49677258 |
| 88 | Delayed CNS myelination (HP:0002188) | 2.49176383 |
| 89 | Sleep apnea (HP:0010535) | 2.46775993 |
| 90 | Spastic tetraplegia (HP:0002510) | 2.44999301 |
| 91 | Muscle fibrillation (HP:0010546) | 2.44478509 |
| 92 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.43682411 |
| 93 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.43682411 |
| 94 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.43190569 |
| 95 | Gait imbalance (HP:0002141) | 2.42761887 |
| 96 | Leukodystrophy (HP:0002415) | 2.42716445 |
| 97 | Gingival bleeding (HP:0000225) | 2.42118607 |
| 98 | Stomatitis (HP:0010280) | 2.41936513 |
| 99 | Abnormality of the corticospinal tract (HP:0002492) | 2.40692437 |
| 100 | Cerebral edema (HP:0002181) | 2.39363304 |
| 101 | Abnormality of B cell number (HP:0010975) | 2.38014221 |
| 102 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.37479783 |
| 103 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.37479783 |
| 104 | Renal Fanconi syndrome (HP:0001994) | 2.36385094 |
| 105 | Microvesicular hepatic steatosis (HP:0001414) | 2.35620715 |
| 106 | Increased CSF lactate (HP:0002490) | 2.35336210 |
| 107 | Psychosis (HP:0000709) | 2.32305051 |
| 108 | Neoplasm of head and neck (HP:0012288) | 2.32225683 |
| 109 | Esophageal neoplasm (HP:0100751) | 2.32225683 |
| 110 | Anxiety (HP:0000739) | 2.30708085 |
| 111 | Truncal ataxia (HP:0002078) | 2.30695892 |
| 112 | Nasal speech (HP:0001611) | 2.29125327 |
| 113 | Abnormal gallbladder morphology (HP:0012437) | 2.28483751 |
| 114 | Type I transferrin isoform profile (HP:0003642) | 2.28373083 |
| 115 | Termporal pattern (HP:0011008) | 2.28025721 |
| 116 | Insidious onset (HP:0003587) | 2.28025721 |
| 117 | Cone-rod dystrophy (HP:0000548) | 2.27775140 |
| 118 | Hyperglycinuria (HP:0003108) | 2.27507618 |
| 119 | Cholelithiasis (HP:0001081) | 2.27094494 |
| 120 | Hypoplastic female external genitalia (HP:0012815) | 2.26102038 |
| 121 | Tubulointerstitial nephritis (HP:0001970) | 2.25643903 |
| 122 | Amaurosis fugax (HP:0100576) | 2.23681386 |
| 123 | Stomach cancer (HP:0012126) | 2.22975298 |
| 124 | Agammaglobulinemia (HP:0004432) | 2.22924710 |
| 125 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.22738845 |
| 126 | Dicarboxylic aciduria (HP:0003215) | 2.22738845 |
| 127 | Generalized myoclonic seizures (HP:0002123) | 2.19361787 |
| 128 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.17912208 |
| 129 | Growth hormone deficiency (HP:0000824) | 2.16488916 |
| 130 | Congenital primary aphakia (HP:0007707) | 2.16279363 |
| 131 | Metaphyseal dysplasia (HP:0100255) | 2.16182308 |
| 132 | Abnormal biliary tract physiology (HP:0012439) | 2.14923545 |
| 133 | Bile duct proliferation (HP:0001408) | 2.14923545 |
| 134 | Long foot (HP:0001833) | 2.13591925 |
| 135 | Increased hepatocellular lipid droplets (HP:0006565) | 2.13540048 |
| 136 | Congenital stationary night blindness (HP:0007642) | 2.11800744 |
| 137 | Hypogonadotrophic hypogonadism (HP:0000044) | 2.11010542 |
| 138 | Seborrheic dermatitis (HP:0001051) | 2.10393907 |
| 139 | Decreased muscle mass (HP:0003199) | 2.10220978 |
| 140 | Akinesia (HP:0002304) | 2.10032687 |
| 141 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.09051003 |
| 142 | Abnormality of glycine metabolism (HP:0010895) | 2.09051003 |
| 143 | Myelodysplasia (HP:0002863) | 2.07777083 |
| 144 | Portal hypertension (HP:0001409) | 2.07146911 |
| 145 | Depression (HP:0000716) | 2.06982132 |
| 146 | Muscular hypotonia of the trunk (HP:0008936) | 2.05763702 |
| 147 | Myositis (HP:0100614) | 2.04777860 |
| 148 | Spontaneous abortion (HP:0005268) | 2.03398571 |
| 149 | Hypoplasia of the brainstem (HP:0002365) | 2.02905779 |
| 150 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.02905779 |
| 151 | Nephrogenic diabetes insipidus (HP:0009806) | 2.02825400 |
| 152 | Macular degeneration (HP:0000608) | 2.02071015 |
| 153 | Ketosis (HP:0001946) | 2.00555495 |
| 154 | Intellectual disability, profound (HP:0002187) | 2.00464114 |
| 155 | Bradykinesia (HP:0002067) | 2.00085247 |
| 156 | Medial flaring of the eyebrow (HP:0010747) | 1.99914119 |
| 157 | Arterial thrombosis (HP:0004420) | 1.99089185 |
| 158 | Diplopia (HP:0000651) | 1.98631119 |
| 159 | Abnormality of binocular vision (HP:0011514) | 1.98631119 |
| 160 | Conjunctival hamartoma (HP:0100780) | 1.96621132 |
| 161 | Exertional dyspnea (HP:0002875) | 1.94445404 |
| 162 | Scanning speech (HP:0002168) | 1.93151785 |
| 163 | Urinary urgency (HP:0000012) | 1.92770108 |
| 164 | Abnormality of the gallbladder (HP:0005264) | 1.92019678 |
| 165 | Scotoma (HP:0000575) | 1.91629732 |
| 166 | Lethargy (HP:0001254) | 1.90292617 |
| 167 | Abnormality of male internal genitalia (HP:0000022) | 1.90253939 |
| 168 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.89522752 |
| 169 | Methylmalonic aciduria (HP:0012120) | 1.88803195 |
| 170 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.88099114 |
| 171 | Impaired vibratory sensation (HP:0002495) | 1.87451285 |
| 172 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.87065385 |
| 173 | Abnormality of alanine metabolism (HP:0010916) | 1.87065385 |
| 174 | Hyperalaninemia (HP:0003348) | 1.87065385 |
| 175 | Hepatic necrosis (HP:0002605) | 1.86108790 |
| 176 | Fetal akinesia sequence (HP:0001989) | 1.85476290 |
| 177 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.84674353 |
| 178 | Abnormality of the hepatic vasculature (HP:0006707) | 1.84545343 |
| 179 | Progressive inability to walk (HP:0002505) | 1.84206143 |
| 180 | Acute hepatic failure (HP:0006554) | 1.84183290 |
| 181 | Thrombophlebitis (HP:0004418) | 1.83405291 |
| 182 | Premature ovarian failure (HP:0008209) | 1.83100093 |
| 183 | Cerebral palsy (HP:0100021) | 1.82418435 |
| 184 | Short hallux (HP:0010109) | 1.81887792 |
| 185 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.81272016 |
| 186 | Chest pain (HP:0100749) | 1.80794784 |
| 187 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.80631783 |
| 188 | Pigmentary retinal degeneration (HP:0001146) | 1.80526205 |
| 189 | Chronic otitis media (HP:0000389) | 1.79708821 |
| 190 | Lactic acidosis (HP:0003128) | 1.78331671 |
| 191 | Pancytopenia (HP:0001876) | 1.77245489 |
| 192 | Constricted visual fields (HP:0001133) | 1.75254150 |
| 193 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.75060662 |
| 194 | Type 2 muscle fiber atrophy (HP:0003554) | 1.74854483 |
| 195 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.74460863 |
| 196 | Nephronophthisis (HP:0000090) | 1.73849577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 5.03998600 |
| 2 | MAP3K4 | 4.97210422 |
| 3 | GRK7 | 4.95924224 |
| 4 | MAP2K7 | 4.88703031 |
| 5 | TAOK3 | 4.81275427 |
| 6 | BCKDK | 4.16147483 |
| 7 | CASK | 3.50265072 |
| 8 | NUAK1 | 3.42875524 |
| 9 | TIE1 | 3.37722461 |
| 10 | PBK | 2.98123649 |
| 11 | MAP2K4 | 2.93233674 |
| 12 | KIT | 2.82537117 |
| 13 | CAMK4 | 2.72924608 |
| 14 | PINK1 | 2.69553806 |
| 15 | AKT3 | 2.69198185 |
| 16 | STK10 | 2.51521496 |
| 17 | CAMK1 | 2.50085826 |
| 18 | RPS6KL1 | 2.32201810 |
| 19 | RPS6KC1 | 2.32201810 |
| 20 | KDR | 2.12695674 |
| 21 | MAP4K1 | 2.08663362 |
| 22 | MYLK | 2.01411066 |
| 23 | RPS6KA6 | 1.99492144 |
| 24 | TEC | 1.97832598 |
| 25 | DAPK1 | 1.97233419 |
| 26 | NTRK2 | 1.97124976 |
| 27 | EIF2AK3 | 1.94029339 |
| 28 | ZAK | 1.91955877 |
| 29 | FLT3 | 1.91002464 |
| 30 | TSSK6 | 1.88456846 |
| 31 | MAP4K2 | 1.86787256 |
| 32 | SCYL2 | 1.82913541 |
| 33 | NME1 | 1.82588770 |
| 34 | PLK2 | 1.71097506 |
| 35 | PDK4 | 1.67238371 |
| 36 | PDK3 | 1.67238371 |
| 37 | LRRK2 | 1.63212313 |
| 38 | MATK | 1.54532033 |
| 39 | NTRK3 | 1.53763671 |
| 40 | MAP3K11 | 1.53113956 |
| 41 | ARAF | 1.52002715 |
| 42 | TBK1 | 1.48951437 |
| 43 | CDK19 | 1.39927960 |
| 44 | MINK1 | 1.36658195 |
| 45 | UHMK1 | 1.32934668 |
| 46 | DAPK2 | 1.30661720 |
| 47 | CAMK2A | 1.27095944 |
| 48 | MAP3K9 | 1.26223738 |
| 49 | MARK1 | 1.24647238 |
| 50 | BMPR1B | 1.24202192 |
| 51 | CSF1R | 1.23084655 |
| 52 | SGK494 | 1.21963076 |
| 53 | SGK223 | 1.21963076 |
| 54 | TNK2 | 1.20572726 |
| 55 | PRKG2 | 1.19938404 |
| 56 | PIK3CG | 1.19495096 |
| 57 | FRK | 1.17497349 |
| 58 | MAPK13 | 1.17359517 |
| 59 | GRK5 | 1.16537170 |
| 60 | NEK1 | 1.14660964 |
| 61 | SGK2 | 1.13341567 |
| 62 | PRKCG | 1.11816163 |
| 63 | ADRBK1 | 1.10439855 |
| 64 | JAK3 | 1.09615363 |
| 65 | MAP3K13 | 1.05366496 |
| 66 | PRKCE | 1.02994092 |
| 67 | MAP3K6 | 1.02610715 |
| 68 | PLK4 | 1.02115777 |
| 69 | BTK | 0.98507700 |
| 70 | MAP3K14 | 0.96581216 |
| 71 | MKNK1 | 0.96540969 |
| 72 | TXK | 0.95886827 |
| 73 | OXSR1 | 0.95660158 |
| 74 | CCNB1 | 0.95336902 |
| 75 | FES | 0.95186275 |
| 76 | CAMK2B | 0.94925340 |
| 77 | BRAF | 0.92918879 |
| 78 | VRK2 | 0.92056127 |
| 79 | EPHA4 | 0.90109334 |
| 80 | SGK3 | 0.88056244 |
| 81 | PDK2 | 0.87409579 |
| 82 | IKBKE | 0.85901746 |
| 83 | DAPK3 | 0.84765138 |
| 84 | MAP2K3 | 0.84078177 |
| 85 | GRK1 | 0.81710350 |
| 86 | CDK5 | 0.81251350 |
| 87 | PRPF4B | 0.79976594 |
| 88 | ALK | 0.77912311 |
| 89 | ITK | 0.77881500 |
| 90 | PRKD3 | 0.75736905 |
| 91 | TAF1 | 0.75086196 |
| 92 | PRKD2 | 0.74521633 |
| 93 | IKBKB | 0.72132321 |
| 94 | NME2 | 0.71028209 |
| 95 | RPS6KA2 | 0.68842842 |
| 96 | LCK | 0.68222519 |
| 97 | BRSK2 | 0.67710330 |
| 98 | CDK3 | 0.67439352 |
| 99 | RPS6KA5 | 0.66248367 |
| 100 | PRKCH | 0.65831454 |
| 101 | LIMK1 | 0.64988746 |
| 102 | TRIM28 | 0.63963721 |
| 103 | VRK1 | 0.63586404 |
| 104 | SIK3 | 0.61779905 |
| 105 | IGF1R | 0.61612372 |
| 106 | MAP2K2 | 0.61208561 |
| 107 | TGFBR1 | 0.59437189 |
| 108 | CAMK2D | 0.58602299 |
| 109 | PHKG1 | 0.56494960 |
| 110 | PHKG2 | 0.56494960 |
| 111 | TLK1 | 0.56392784 |
| 112 | MAP2K1 | 0.55930947 |
| 113 | CAMK2G | 0.55894850 |
| 114 | CSNK1G1 | 0.51935063 |
| 115 | PIM2 | 0.51897107 |
| 116 | FER | 0.50952935 |
| 117 | WNK3 | 0.50648266 |
| 118 | MAP3K5 | 0.50106008 |
| 119 | ERBB3 | 0.50089547 |
| 120 | HCK | 0.50087387 |
| 121 | RPS6KB2 | 0.49674782 |
| 122 | ROCK2 | 0.49527074 |
| 123 | CAMKK1 | 0.48005576 |
| 124 | CSNK1G3 | 0.47767806 |
| 125 | EIF2AK2 | 0.46591223 |
| 126 | CDK18 | 0.44174893 |
| 127 | CDK14 | 0.43148792 |
| 128 | LYN | 0.41947697 |
| 129 | YES1 | 0.41607642 |
| 130 | NTRK1 | 0.41480646 |
| 131 | PRKACG | 0.41135118 |
| 132 | INSRR | 0.40865956 |
| 133 | CDK15 | 0.39395694 |
| 134 | CDK9 | 0.39102836 |
| 135 | MST4 | 0.38878848 |
| 136 | LMTK2 | 0.38541267 |
| 137 | MAPK3 | 0.38515313 |
| 138 | CDC7 | 0.38063544 |
| 139 | RPS6KB1 | 0.37767165 |
| 140 | PTK2B | 0.37345530 |
| 141 | PRKACA | 0.37238974 |
| 142 | PRKCD | 0.35775796 |
| 143 | SGK1 | 0.35323346 |
| 144 | MAP3K1 | 0.34368843 |
| 145 | PLK3 | 0.34253600 |
| 146 | ERBB4 | 0.33789244 |
| 147 | PRKCA | 0.33097177 |
| 148 | BCR | 0.29850036 |
| 149 | TRPM7 | 0.29664818 |
| 150 | MAP3K8 | 0.29103928 |
| 151 | CDK11A | 0.28463168 |
| 152 | STK24 | 0.27604045 |
| 153 | PAK4 | 0.27520594 |
| 154 | TNIK | 0.27028286 |
| 155 | RPS6KA4 | 0.26908596 |
| 156 | PRKCB | 0.26819312 |
| 157 | MKNK2 | 0.25462843 |
| 158 | GRK6 | 0.25031104 |
| 159 | MAP2K6 | 0.24958627 |
| 160 | SRC | 0.24929713 |
| 161 | NLK | 0.24794858 |
| 162 | MARK2 | 0.23865297 |
| 163 | PAK3 | 0.20794251 |
| 164 | FYN | 0.20076761 |
| 165 | PRKCQ | 0.19546233 |
| 166 | ADRBK2 | 0.19243317 |
| 167 | PDK1 | 0.18593985 |
| 168 | BMPR2 | 0.17455746 |
| 169 | SYK | 0.17440556 |
| 170 | RPS6KA3 | 0.17034380 |
| 171 | PRKG1 | 0.15290606 |
| 172 | CSNK1G2 | 0.15128806 |
| 173 | CSNK1E | 0.14424124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 4.31638721 |
| 2 | Arginine biosynthesis_Homo sapiens_hsa00220 | 4.05821343 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.93215346 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.77884257 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.57316591 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.22584945 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.88874170 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.68622674 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.56512155 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.55824036 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.38832903 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.35930715 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.32548628 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.32353931 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20260991 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 2.15693638 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.13388365 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 2.12812979 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.12000744 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.11776166 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 2.07968265 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.99529801 |
| 23 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.96311740 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.95573697 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.95351398 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 1.89293296 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84024657 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.81246580 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.78967111 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.78070242 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.66386385 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64453547 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.60515831 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.57409629 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56533624 |
| 36 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.56215048 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53129475 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.53080237 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.50260101 |
| 40 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.50001095 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.48717515 |
| 42 | Base excision repair_Homo sapiens_hsa03410 | 1.47191712 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46922035 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46194173 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44863312 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.44241389 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42173035 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40680606 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.38732065 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.38306315 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34953272 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 1.34629023 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.32011940 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.31814741 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.31680724 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30575319 |
| 57 | Long-term potentiation_Homo sapiens_hsa04720 | 1.29805037 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29415533 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 1.23380071 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.23319790 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.22247050 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21547736 |
| 63 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.19412805 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17852085 |
| 65 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.16672388 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13906596 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.13633533 |
| 68 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13317289 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12648059 |
| 70 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.09534919 |
| 71 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07952068 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.07925260 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.06633011 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04796224 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.03188866 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03042899 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99521773 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98979945 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96851273 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.96804796 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.96530942 |
| 82 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95746644 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95147955 |
| 84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.94692918 |
| 85 | Insulin secretion_Homo sapiens_hsa04911 | 0.94175369 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93703302 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92473714 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90119019 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85044439 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83813582 |
| 91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.81584043 |
| 92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.80872557 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80295629 |
| 94 | Purine metabolism_Homo sapiens_hsa00230 | 0.78740464 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.77468827 |
| 96 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75951907 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74738795 |
| 98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73492738 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73149522 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.73013982 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72413237 |
| 102 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71342281 |
| 103 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70570844 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68060491 |
| 105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67449099 |
| 106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66734335 |
| 107 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66093324 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65966638 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65836261 |
| 110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.64782778 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64109731 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63676453 |
| 113 | Ribosome_Homo sapiens_hsa03010 | 0.63203790 |
| 114 | Cocaine addiction_Homo sapiens_hsa05030 | 0.63203510 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63136164 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62706784 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62374415 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61300577 |
| 119 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59440855 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59242036 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57282309 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54677657 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54299322 |
| 124 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.54023029 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.53100003 |
| 126 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51825690 |
| 127 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51737856 |
| 128 | Alcoholism_Homo sapiens_hsa05034 | 0.51054661 |
| 129 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50989570 |
| 130 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48853205 |
| 131 | RNA polymerase_Homo sapiens_hsa03020 | 0.47815698 |
| 132 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43954617 |
| 133 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.43026247 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40264908 |
| 135 | Pertussis_Homo sapiens_hsa05133 | 0.38728878 |
| 136 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38043895 |
| 137 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36806734 |
| 138 | Homologous recombination_Homo sapiens_hsa03440 | 0.36731811 |
| 139 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36478103 |
| 140 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.36385152 |
| 141 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36014404 |
| 142 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35794097 |
| 143 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34700524 |
| 144 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34434697 |
| 145 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32886164 |
| 146 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.32806959 |
| 147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30528000 |
| 148 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28773016 |
| 149 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.23441188 |
| 150 | Shigellosis_Homo sapiens_hsa05131 | 0.22628830 |
| 151 | Axon guidance_Homo sapiens_hsa04360 | 0.22253794 |
| 152 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.19665461 |
| 153 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.18805518 |
| 154 | Proteasome_Homo sapiens_hsa03050 | 0.16173199 |
| 155 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15118289 |
| 156 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.14068813 |
| 157 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13884840 |
| 158 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.13286603 |
| 159 | Melanogenesis_Homo sapiens_hsa04916 | 0.12855023 |
| 160 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12712610 |
| 161 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12332450 |
| 162 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.12127505 |
| 163 | Bile secretion_Homo sapiens_hsa04976 | 0.11672290 |
| 164 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.11102893 |
| 165 | Metabolic pathways_Homo sapiens_hsa01100 | 0.10980397 |
| 166 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09776837 |
| 167 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.09617235 |
| 168 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.08329437 |
| 169 | Prion diseases_Homo sapiens_hsa05020 | 0.08100459 |
| 170 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.07985816 |

